Approval · Notice of Compliance 2529 · 2001
PANTOLOC: Notice of Compliance 2529
Issued March 2, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2529
- Date
- March 2, 2001
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of symptomatic gastro-esophageal reflux disease (gerd), such as, acid regurgitation and heartburn
- Therapeutic class
- H+, K+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PANTOLOC | Not yet assigned | — |
Medicinal ingredients
- PANTOPRAZOLE SODIUM 40 MG per TAB
- PANTOPRAZOLE SODIUM 20 MG per TAB